Send to a Friend Font Size: Increase Decrease

AVRX and NXTC Related Headlines

Aug 10, 2026 07:01AM Avere Therapeutics raises $500M in private placement for drug program
Aug 10, 2026 07:00AM Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001

AVRX and NXTC Related Press Releases

Aug 10, 2026 07:00AM Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001

AVRX and NXTC Related SEC Filings